Brouwers AH - Search Results

1

Tc-99m-PEG-Liposomes for the evaluation of colitis in Crohn's disease.

Brouwers AH, De Jong DJ, Dams ET, Oyen WJ, Boerman OC, Laverman P, Naber TH, Storm G, Corstens FH. Brouwers AH, et al. J Drug Target. 2000;8(4):225-33. doi: 10.3109/10611860008997901. J Drug Target. 2000. PMID: 11144233 Clinical Trial.

2

Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.

Laverman P, Brouwers AH, Dams ET, Oyen WJ, Storm G, van Rooijen N, Corstens FH, Boerman OC. Laverman P, et al. Among authors: brouwers ah. J Pharmacol Exp Ther. 2000 Jun;293(3):996-1001. J Pharmacol Exp Ther. 2000. PMID: 10869403

3

A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits.

Brouwers AH, Laverman P, Boerman OC, Oyen WJ, Barrett JA, Harris TD, Edwards DS, Corstens FH. Brouwers AH, et al. Nucl Med Commun. 2000 Nov;21(11):1043-50. doi: 10.1097/00006231-200011000-00010. Nucl Med Commun. 2000. PMID: 11192710

4

131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.

Brouwers AH, Dorr U, Lang O, Boerman OC, Oyen WJ, Steffens MG, Oosterwijk E, Mergenthaler HG, Bihl H, Corstens FH. Brouwers AH, et al. Nucl Med Commun. 2002 Mar;23(3):229-36. doi: 10.1097/00006231-200203000-00005. Nucl Med Commun. 2002. PMID: 11891480 Clinical Trial.

5

Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.

Steffens MG, Mulders PF, Brouwers AH, Oyen WJ. Steffens MG, et al. Among authors: brouwers ah. J Urol. 2002 Nov;168(5):2127-8. doi: 10.1016/S0022-5347(05)64320-0. J Urol. 2002. PMID: 12394731 No abstract available.

6

Monoclonal antibody-based therapy for renal cell carcinoma.

Oosterwijk E, Divgi CR, Brouwers A, Boerman OC, Larson SM, Mulders P, Old LJ. Oosterwijk E, et al. Urol Clin North Am. 2003 Aug;30(3):623-31. doi: 10.1016/s0094-0143(03)00028-4. Urol Clin North Am. 2003. PMID: 12953760 Review.

7

Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.

Brouwers AH, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC. Brouwers AH, et al. Cancer Biother Radiopharm. 2003 Aug;18(4):539-47. doi: 10.1089/108497803322287619. Cancer Biother Radiopharm. 2003. PMID: 14503948

8

Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.

Brouwers AH, Buijs WC, Oosterwijk E, Boerman OC, Mala C, De Mulder PH, Corstens FH, Mulders PF, Oyen WJ. Brouwers AH, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3953S-60S. Clin Cancer Res. 2003. PMID: 14506194

9

Monoclonal antibody therapy of kidney cancer.

Oosterwijk E, Brouwers A, Boerman OC, Larson SM, Old LJ, Mulders P, Divgi CR. Oosterwijk E, et al. Cancer Treat Res. 2003;116:199-212. doi: 10.1007/978-1-4615-0451-1_12. Cancer Treat Res. 2003. PMID: 14650834 Review. No abstract available.

10

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.

Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC. Brouwers AH, et al. J Nucl Med. 2004 Feb;45(2):327-37. J Nucl Med. 2004. PMID: 14960657 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters